Clinical Laserthermia Systems AB enters underwriting commitments in the ongoing exercise of warrants of series TO 5 B corresponding to approximately SEK 2.6 million
Lund, Sweden – Clinical Laserthermia Systems AB ("CLS" or the "Company") hereby announces that the Company has agreed on underwriting commitments (so-called “top-down” or “top guarantee”) in the ongoing exercise of warrants of series TO 5 B ("TO 5 B”). The underwriting commitments covers a total of approx. SEK 2.6 million, corresponding to 20 percent of the issue proceeds that the Company can receive through the exercise of TO 5 B. The underwriters have also undertaken to exercise their TO 5 B to subscribe for new B-shares in CLS, corresponding to a total of approximately SEK 100,000.In the